CD4 and non-Hodgkin lymphoma: In a study that looked at 60 HIV+MCD patients, conducted by Oksenhendler et al[5], 14 patients were developed secondary NHL within 0 to 76 months (median time 20 months); however, baseline variable CD4+ T cell counts and plasma HIV-RNA that were related to HIV-infection could not predict the outcomes of NHL conversion.